Sign In
Buy IMUX
$14.17
-0.470 (-3.21%)
At Close: Jun 03, 2026
Immunic Gets FDA Allowance for Phase II Coronavirus Study
05:04pm, Wednesday, 10'th Jun 2020
Immunic (IMUX) gets a FDA allowance to begin a phase II study on its DHODH inhibitor IMU-838 for addressing COVID-19 in the United States. Top-line results on the same are awaited later this year.
Immunic, Inc. Announces Pricing of $25 Million Public Offering of Common Stock
01:16pm, Wednesday, 10'th Jun 2020
Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today an
Immunic, Inc. Announces Proposed Public Offering of Common Stock
11:39pm, Tuesday, 09'th Jun 2020
Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today an
Immunic, Inc. Announces U.S. Food and Drug Administration Allowance of its Phase 2, CALVID-1 Clinical Trial of IMU-838 in COVID-19
11:00am, Tuesday, 09'th Jun 2020
Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today an
Kabul rejects Pak claims of India using Afghan territory
11:16am, Saturday, 06'th Jun 2020
The Ashraf Ghani government has rejected Islamabad`s allegation that Afghanistan was allowing its territories to be used by India to destabilize Pakistan.
Kabul denounces Pakistan's accusations of TTP using Afghan soil to destabilise region
07:24am, Saturday, 06'th Jun 2020
Kabul has rejected the allegations by Pakistan foreign ministry about Tehreek-e-Pakistan (TTP) using Afghan territories by a third party to destabilise regional countries, including Pakistan.
Benzinga's Top Upgrades, Downgrades For June 5, 2020
01:56pm, Friday, 05'th Jun 2020
Upgrades * For Kontoor Brands Inc (NYSE: KTB), Susquehanna upgraded the stock from Neutral to Positive. Interestingly, in the first quarter, Kontoor Brands's EPS was $0.27. The stock has a 52-week-h
May 31, 2020 (The Expresswire) --
Global “Biopharmaceutical Contract Manufacturing(BCMO) Market” is a comprehensive research that provides information...
Immunic, Inc. to Participate in Investor and Industry Conferences in June
10:30am, Friday, 29'th May 2020
Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today an
The
A Black administrator, a white campus, and social change
04:45pm, Wednesday, 20'th May 2020
One of your neighbors posted in Neighbor News. Click through to read what they have to say. (The views expressed in this post are the author’s own.)
Urban Outfitters, Inc. (URBN) CEO Richard Hayne on Q1 2021 Results - Earnings Call Transcript
02:29am, Wednesday, 20'th May 2020
Urban Outfitters, Inc. (NASDAQ:URBN) Q1 2021 Earnings Conference Call May 19, 2020 05:15 p.m. ET Company Representatives Richard Hayne - Chief Executive Officer
Immunic, Inc. to Host Virtual R&D Day Today, May 19, 2020
10:30am, Tuesday, 19'th May 2020
Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, announce
Corporate News for May 15, 2020
02:03pm, Friday, 15'th May 2020
Companies In The News Are: APDN, CSCO, IMUX, VRTU
A Peek Into Immunic's P/E Ratio
03:44pm, Thursday, 14'th May 2020
In the current session, Immunic Inc. (NASDAQ: IMUX) is trading at $11.44, after a 12.35% spike. Over the past month, the stock increased by 48.93%, and in the past year, by 12.58%. With performance li
